• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
GENERAL FARMACOLOGY
GENERAL FARMACOLOGY

... which the drug is completely removed per unit of time. The amount of eliminated drug is proportional to its concentration in the blood CL=rate of elimination/C Half-life (t1/2) of a drug is the time taken for plasma drug concentration to reduce to half its peak level. Volume of Distribution (Vd) is ...
lab#1 pharmacology
lab#1 pharmacology

... 2- Nutrients . 3- Adjusted Physiological pH . 4- Constant temperature . 5- Aeration . ...
Attachment A Comments in Response to the Food and Drug Administration
Attachment A Comments in Response to the Food and Drug Administration

... correspond with those noted in the NPRMs. Improving Patient Information and Consent Issue : FDA regulatory requirements should ensure that patients are well-informed about the risks and benefits of experimental and investigational drugs and therapies before patients can consent to receive them. Disc ...
RAJESH.R NARGUND COLLEGE OF PHARMACY
RAJESH.R NARGUND COLLEGE OF PHARMACY

...  Compression is becoming more prevalent across the pharmaceutical industry as the number of FDC.S increases. The aim of this work develop robust formulation followed by separating as two layer two avoid incompatibility between the drugs by bilayer formulation form.7  Libermann HAetal., Formulated ...
Chapter 16. Side Effects of Drugs in Sjögren`s Syndrome
Chapter 16. Side Effects of Drugs in Sjögren`s Syndrome

... that tests can be carried out to find out if this is indeed the case. Please note that both hydroxychloroquine (Plaquenil®) and chloroquine (Nivaquine®) belong to the chloroquine group in this list. Table 16.2 lists a number of drugs known to sometimes exacerbate an existing MG or trigger symptoms ...
www.omics-ethics.org Revue de littérature: Mars
www.omics-ethics.org Revue de littérature: Mars

... in   the   pre-­‐market   and   post-­‐market   phases   of   drug   evaluation.   The   need   to   improve   pharmacovigilance  methods  concerns  not  only  new  drugs  but  also  existing  drugs  that  have   been   used   for   many   ...
Chapter 21
Chapter 21

... • Effects of combinations of antimicrobial drugs – enhances each other’s effect--- synergistic – interferes with each other’s effect --antagonistic – neither synergistic nor antagonistic effect -additive ...


... as their uniform, statewide price? The uniform price is unlikely to be either the lowest or the highest in the current distribution of zone prices; gasoline wholesale suppliers would face a general averaged demand curve, and neither of those prices is likely to maximize profits. That leaves some pri ...
Combinations student notes 10_lesson_combinationsStudent
Combinations student notes 10_lesson_combinationsStudent

... In this case, one drug has the opposite effect on a symptom compared to the other drug. This might be the case for sedation. Caffeine stimulates wakefulness, while tranquilizers stimulate sleepiness. The drugs oppose each other with regard to inducing sleep/alertness. In fact, any drug pair that has ...
An informative guide to the most commonly used drugs in youth
An informative guide to the most commonly used drugs in youth

... on a trip (such as by trying to fly), driving under the influence, or not recognizing other ...
OTC Meds MATA 2016
OTC Meds MATA 2016

... I tried to avoid deep biochemistry/pharmacology jargon However, I’m always open to new potential conflicts of interest. Why you ask? ...
hypnosis and drugs
hypnosis and drugs

... • 50% had 5 or more drinks in a row in the past two weeks • College students drink more than youths who end their education at h.s. • American college students consume 4 billion cans of beer a year • D or F average = 10.6 drinks per week • A or B average = 3 drinks per week • 95% of violent crime on ...
General Pharmakokinetics
General Pharmakokinetics

... These involve conjugation of the drug or its phase I metabolite with an endogenous substrate to form a polar highly ionized organic acid, which is easily excreted in urine or bile. Conjugation reactions have high energy requirements. (1) Glucoronide conjugation is the most important synthetic reacti ...
Date - Skills Commons
Date - Skills Commons

... This work is licensed under a Creative Commons 3.0 License http://creativecommons.org/licenses/by/3.0 This workforce solution is 100% funded by a grant awarded by the U.S. Department of Labor, Employment and Training Administration, TAACCCT grant agreement # TC-22505-11-60-A25.The solution was crea ...
III Clinical trials
III Clinical trials

... suggested in the labeling there of and has not been recognized as effective and safe by the licensing authority mentioned under rule 21 for the proposed claims. Provided that the limited use, if any has been with the permission of the licensing authority. ...
Pharmacy Technician*s Course. LaGuardia Community College
Pharmacy Technician*s Course. LaGuardia Community College

... Part of the distribution of a drug is how it travels in the blood and lymphatic system. Most drugs travel in the bloodstream bound to an plasma protein like albumin Binding to albumin allows a drug to remain in the body longer A drug that is highly protein bound keep the drug confined to the blood a ...
Drugs
Drugs

... OxyContin by representing it to have "less euphoric effect and less abuse potential" than it actually has, and by claiming that people taking the drug at low doses could stop taking it suddenly without symptoms of withdrawal. The FDA had not approved these claims. The company and the executives were ...
General Pharmacokinetics
General Pharmacokinetics

... These involve conjugation of the drug or its phase I metabolite with an endogenous substrate to form a polar highly ionized organic acid, which is easily excreted in urine or bile. Conjugation reactions have high energy requirements. (1) Glucoronide conjugation is the most important synthetic reacti ...
Oral Anticancer Drugs
Oral Anticancer Drugs

... For an oral anticancer drug to be covered, all of the following criteria must be met: Drug or biological has been approved by the FDA; and It has the same active ingredients as a non-self-administrable anticancer chemotherapeutic drug or biological that is covered when furnished incident to a ...
Drugs Safety in Pregnancy
Drugs Safety in Pregnancy

... dednemmocer ADR gnideecxe esod C/A(Vitamin A Category* )esod dednemmocer ADR gnideecxe esodC/A yrogetaC Vitamin C* )esod dednemmocer ADR gnideecxe esod C/A yrogetaC Vitamin E* )esod dednemmocer ADR gnideecxe esodC/A Vitamin B Category* )esod Vitamin D CategoryC* C yrogetaC Vitamin K* ...
Tuberculosis - Current Advances in Development of New Drugs
Tuberculosis - Current Advances in Development of New Drugs

... 16. Dey T., et al. “Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis”. Journal of Antimicrobial Chemotherapy 68.2 (2013): 284-293. 17. Lechartier B., et al. “Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones a ...
Drug Resistance - World Health Organization
Drug Resistance - World Health Organization

... for use, and always completing courses of medicine. When people only take part of a course of treatment, this contributes to the development of drug resistance. 7. What can doctors do? >> Doctors can come under pressure from patients and inappropriate pharmaceutical marketing to prescribe medicines ...
LADMER System
LADMER System

... • Affects orally administered drugs • Metabolism of drug by liver before drug reaches systemic circulation • Drug absorbed into portal circulation, must pass through liver to reach systemic circulation • May reduce availability of drug ...
NEW Psychoactive DRUGS
NEW Psychoactive DRUGS

... developing new drugs with similar effects to illegal ones. These products are not classified by existing legislation and vendors are able to avoid existing laws by labelling these drugs with terms such as ‘not for human consumption’. However this can cause greater harm as it prevents the shop employ ...
“The Supporting Players….”
“The Supporting Players….”

... Aerosolized for PCP/PJP infections in HIV patients Pneumocystis Carinii Pneumonia now known as Pneumocystis Jiroveci Pneumonia Can be very toxic ...
< 1 ... 107 108 109 110 111 112 113 114 115 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report